[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334130-105":59,"doc-detail-334130-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","functional-annotation-of-the-hippo-pathway-somatic-mutations-in-human-cancers","Functional annotation of the Hippo pathway somatic mutations in human cancers","","Functional annotation dissects how Hippo pathway somatic mutations contribute to cancer development. The study surveys human cancer genomes and identifies 85 loss-of-function missense mutations across Hippo pathway genes, clarifying their roles in pathway targeting. It shows a zinc-finger domain as essential for MOB1 function, where related loss-of-function variants enhance tumor growth in head and neck cancer. It further finds NF2 loss-of-function mutations both disable tumor-suppressive Hippo activity and create an oncogenic VANGL-JNK–activating function. The work provides a curated mutation resource and molecular rationale for Hippo-based therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/functional-annotation-of-the-hippo-pathway-somatic-mutations-in-human-cancers/334130/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/functional-annotation-of-the-hippo-pathway-somatic-mutations-in-human-cancers/334130.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on Hippo pathway mutations?","Question",{"text":112,"@type":113},"To analyze Hippo somatic mutations in human cancer genomes and functionally annotate how they target and dysregulate the Hippo pathway to promote cancer development.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many Hippo pathway loss-of-function mutations are identified?",{"text":117,"@type":113},"The study identifies a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional roles do MOB1 and NF2 mutations play in cancer?",{"text":121,"@type":113},"The work shows zinc-finger domain–based MOB1 integrity is crucial, and its LOF mutations promote tumor growth in head and neck cancer. It also shows NF2 LOF mutations inhibit tumor-suppressive Hippo function while gaining an oncogenic role by activating the VANGL-JNK pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334130,1790170924,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article [https://doi.org/10.1038/s41467-024-54480-y](https://doi.org/10.1038/s41467-024-54480-y)  \nFunctional annotation of the Hippo pathway somatic mutations in human cancers  \nReceived: 5 February 2024  \n\n| Accepted: 12 November 2024 |\n| --- |\n| |\n| Check for updates |\n\nHan Han 1,2,3,14 , Zhen Huang4,14, Congsheng Xu5,14, Gayoung Seo3, Jeongmin An 3, Bing Yang3, Yuhan Liu3, Tian Lan3, Jiachen Yan3, Shanshan Ren5, Yue Xu1,2, Di Xiao1,2, Jonathan K. Yan3, Claire Ahn3, Dmitry A. Fishman 6, Zhipeng Meng 7, Kun-Liang Guan 8, Ruxi Qi9 , Ray Luo 10,11,12,13  & Wenqi Wang 3   \nThe Hippo pathway is commonly altered in cancer initiation and progression; however, exactly how this pathway becomes dysregulated to promote human cancer development remains unclear. Here we analyze the Hippo somatic mutations in the human cancer genome and functionally annotate their roles in targeting the Hippo pathway. We identify a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes and elucidate their underlying mechanisms. Interestingly, we reveal zinc-ﬁnger domain as an integral structure for MOB1 function, whose LOF mutations in head and neck cancer promote tumor growth. Moreover, the schwannoma/meningioma-derived NF2 LOF mutations not only inhibit its tumor suppressive function in the Hippo pathway, but also gain an oncogenic role for NF2 by activating the VANGL-JNK pathway. Collectively, our study not only offers a rich somatic mutation resource for investigating the Hippo pathway in human cancers, but also provides a molecular basis for Hippo-based cancer therapy.  \nThe Hippo pathway is a key regulator of development, regeneration, organ size, tissue homeostasis, and cancer1–4. It senses and transducesa wide range of growth-related signals to restrict proliferation and stimulate apoptosis, two events that are frequently lost during tumorigenesis. However, precisely how the Hippo pathway becomes dysregulated in tumorigenesis and how such alterations affect the Hippo pathway to drive human cancer development have not been fully understood.  \nThe mammalian Hippo pathway comprises two STE20-like kinases MST1 and MST2 (MST1/2), two AGC family of kinases LATS1 and LATS2 (LATS1/2), and their adaptor proteins SAV1 and MOB1A and MOB1B (MOB1A/B), respectively. NF2is a membrane-bound Hippo component required for LATS1/2 membrane translocation and activation5. As additional core kinase components, MAP4K1-7 actin parallel to MST1/2 to phosphorylate and activate LATS1/26–10. Once activated, LATS1/2 phosphorylate two transcriptional co-activators, YAP and TAZ,  \n1Department of Pathophysiology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China. 2TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China. 3Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA. 4Chemical and Materials Physics Graduate Program, University of California, Irvine, Irvine, CA, USA. 5Department of Chemistry and Shenzhen Grubbs Institute, Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen, Guangdong, China. 6Department of Chemistry, University of California, Irvine, Irvine, CA, USA. 7Department of Molecular and Cellular Pharmacology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. 8School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. 9Cryo-EM Center, Southern University of Science and Technology, Shenzhen, Guangdong, China. 10Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA. 11Department of Chemical and Biomolecular Engineering, University of California, Irvine, Irvine, CA, USA. 12Department of Materials Science and Engineering, University of California, Irvine, Irvine, CA, USA. 13Department of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA. 14T","cbCainpxBr9z1L4K","https://ap.wps.com/l/cbCainpxBr9z1L4K","pdf",7783878,18,"English","# Abstract\n## Study focus: Hippo somatic mutations in human cancers\n## Key findings: LOF mutations, MOB1 zinc-finger function, NF2 oncogenic role\n## Implications: mutation resource and Hippo-based therapy rationale","[{\"question\":\"What is the main goal of this study on Hippo pathway mutations?\",\"answer\":\"To analyze Hippo somatic mutations in human cancer genomes and functionally annotate how they target and dysregulate the Hippo pathway to promote cancer development.\"},{\"question\":\"How many Hippo pathway loss-of-function mutations are identified?\",\"answer\":\"The study identifies a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes.\"},{\"question\":\"What functional roles do MOB1 and NF2 mutations play in cancer?\",\"answer\":\"The work shows zinc-finger domain–based MOB1 integrity is crucial, and its LOF mutations promote tumor growth in head and neck cancer. It also shows NF2 LOF mutations inhibit tumor-suppressive Hippo function while gaining an oncogenic role by activating the VANGL-JNK pathway.\"}]","Functional annotation of the Hippo pathway somatic mutations in human cancers | PDF",1790005422,45]